收藏切换
Research progress of immune checkpoint inhibitor-induced acute kidney injury
收藏切换
Long WANG1, Rong JIN2, Yi-xuan HAN1, Juan WANG3, Ling-na ZHU1
Chinese Journal of New Drugs | 2021, 30(1) : 38 - 42
Less
收藏切换
Chinese Journal of New Drugs | 2021, 30(1): 38-42
Research progress of immune checkpoint inhibitor-induced acute kidney injury
Full
Long WANG1, Rong JIN2, Yi-xuan HAN1, Juan WANG3, Ling-na ZHU1
Affiliations
  • 1Department of Pharmacy, the Third People's Hospital of Bengbu, Bengbu 233099, China
  • 2Department of Pharmacy, Ningxia Hospital of Traditional Chinese Medicine and Research Institute of Traditional Chinese Medicine, Yinchuan 750021, China
  • 3Department of Emergency, East City Hospital of Shanghai Yangpu District, Shanghai 200438, China
Published: 2021-01-15
Outline
收藏切换

Immune checkpoint inhibitors (ICPis), a kind of monoclonal antibodies that target inhibitory receptors expressed on T cells, represent an emerging class of immunotherapy used in treating solid organ and hematologic malignancies. Unfortunately, ICPis have also been associated with the emergence of a new subsets of autoimmune-like toxicities, known as immune-related adverse events (irAEs). Acute kidney injury (AKI) is one of the common irAEs. This paper reviews the clinical manifestations, incidence, risk factors, mechanisms and treatment of ICPi-induced AKI. The risk of ICPi-induced AKI is significantly higher than that induced by chemotherapeutic drugs, and the involved risk factors include the type of ICPi drug and the proton pump inhibitors (PPIs). The typical symptom of ICPi-induced AKI is increased serum levels of creatinine and pyuria. The typical histopathological features are acute tubulointerstitial nephritis (ATIN). During ICPi treatment, renal function should be closely monitored to detect and intervene AKI early. The main treatment is glucocorticoid therapy, and immunosuppressive drugs can be added when necessary. This study provides reference for the clinical safety application of ICPi in China with a view to improve the prognosis of cancer patients and make them more beneficial.

immune checkpoint inhibitors (ICPi)  /  acute kidney injury (AKI)  /  immune-related adverse effects (irAEs)
汪龙, 金荣, 韩一萱, 汪娟, 朱玲娜. 免疫检查点抑制剂致急性肾损伤的研究进展. 中国新药杂志, 2021 , 30 (1) : 38 -42 .
Long WANG, Rong JIN, Yi-xuan HAN, Juan WANG, Ling-na ZHU. Research progress of immune checkpoint inhibitor-induced acute kidney injury[J]. Chinese Journal of New Drugs, 2021 , 30 (1) : 38 -42 .
Year 2021 volume 30 Issue 1
30
8
Cite this Article
BibTeX
Article Info
  • Online Date:2026-10-29
  • Published:2021-01-15
Article Data
Affiliations
History
  • Accepted:2019-12-20
Affiliations
    1Department of Pharmacy, the Third People's Hospital of Bengbu, Bengbu 233099, China
    2Department of Pharmacy, Ningxia Hospital of Traditional Chinese Medicine and Research Institute of Traditional Chinese Medicine, Yinchuan 750021, China
    3Department of Emergency, East City Hospital of Shanghai Yangpu District, Shanghai 200438, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT